TITLE

ANTI-INFLAMMATORY EFFECT OF N-ACETYLCYSTEINE (NAC) IN A MODEL OF COLITIS

AUTHOR(S)
Azooz, O.G.; De Silva, A.; Rampton, D.S.; Ballinger, A.B.
PUB. DATE
April 2003
SOURCE
Gut;Apr2003 Supplement 1, Vol. 52, pA61
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Introduction: Oxidative stress is a potential mechanism in the pathogenesis of inflammatory bowel disease (IBD) where reactive oxygen species (ROS) ore produced in excess by the intestinal mucosa. N-acetylcysteine (NAC) is a synthetic thiol compound which has antioxidant properties and suppresses production of NK-κB, and proinflammatory cytokines including TNF-α. Aims: The aim of this study was to assess the effect of NAC on the severity of colonic inflammation in a rat model of colitis. Methods: Colitis was induced in Wistar rats by intrarectal administration of 2,4,6 trinitrobenzenesulphonic acid (TNBS) and rats treated with i.p. NAC (50 or 200 mg/kg/day) or saline control (8/group). 16 healthy controls were treated with either NAC (50 mg/kg/day) or saline. Animals were sacrificed 5 days after induction of colitis. Severity of intestinal inflammation was assessed macroscopically, and by measurement of colonic tissue myeloperoxidase (MPO) and water content. ROS were measured by chemiluminescence (CLS). Results: TNBS induced distal colitis with ulceration, increased tissue MPO concentration and water content, and CLS (table). NAC reduced all these measures of intestinal inflammation except water content. There was no significant difference between 200 and 50 mg/kg of NAC. Conclusion: NAC has anti-inflammatory effects in the acute phase of TNBS-induced colitis. This treatment may be worth further assessment in the treatment of human IBD.
ACCESSION #
9747698

 

Related Articles

  • Decreased Incorporation of 14C-Glucosamine Relative to 3H-N-Acetyl Glucosamine in the Intestinal Mucosa of Patients with Inflammatory Bowel Disease. Burton, A. F.; Anderson, F. H. // American Journal of Gastroenterology;Jan1983, Vol. 78 Issue 1, p19 

    The synthesis of glycoproteins was investigated in intestinal mucosa from patients with inflammatory bowel disease (IBD) and from those with various other conditions. The incorporation into acid-insoluble macromolecules of the amino sugar glucosamine, the first and committed metabolite in the...

  • Recent Understanding of Leukocytapheresis (LCAP) for the Treatment of Inflammatory Bowel Disease. Mitsuyama, Keiichi; Yamasaki, Hiroshi; Kuwaki, Kotaro; Takedatsu, Hidetoshi; Sata, Michio // Current Pharmaceutical Design;6/21/2009, Vol. 15 Issue 18, p2110 

    Inflammatory bowel disease (IBD) is frequently associated with the infiltration of a large number of leukocytes into the bowel mucosa. Therefore, the removal of circulating leukocytes may be an attractive approach for the treatment of IBD. Leukocytapheresis with Cellsorba, a column of...

  • Site of Origin of Dysplastic Epithelium in Colonic Mucosa. LEV, ROBERT; GUANG-YU YANG // Archives of Pathology & Laboratory Medicine;May2014, Vol. 138 Issue 5, p583 

    A letter to the editor and a reply are presented in response to the article "Dysplastic lesions in inflammatory bowel disease: molecular pathogenesis to morphology," by K. A. Matkowskyj, Z. E. Chen, M. S. Rao, and G. Y. Yang in the 2013 issue.

  • Antioxidants and mucosa protectives: realistic therapeutic options in inflammatory bowel disease? Kruidenier, L.; Verspaget, H. W. // Mediators of Inflammation;Jun98, Vol. 7 Issue 3, p157 

    OXIDATIVE damage is involved in the pathogenic process of idiopathic chronic inflammatory bowel disease. Although specific intervention in the oxidative cascade showed promising results in animal models and preliminary patient trials, the clinical efficacy of antioxidants still has to be...

  • Immune-non Immune Networks in Intestinal Inflammation. Hausmann, Martin; Rogler, Gerhard // Current Drug Targets;May2008, Vol. 9 Issue 5, p388 

    The intestinal mucosa forms a primary barrier providing both barrier function and immediate effective recognition of bacterial products invading the mucosa. This is of great importance for the prevention of permanent and chronic inflammation as a reaction to the commensal intestinal flora and...

  • Increased expression of tumor necrosis factor-α messenger RNA in the intestinal mucosa of inflammatory bowel disease, particularly in patients with disease in the inactive phase. Akazawa, Akiko; Sakaida, Isao; Higaki, Shingo; Kubo, Yoshitsugu; Uchida, Koichi; Okita, Kiwamu // Journal of Gastroenterology;2002, Vol. 37 Issue 5, p345 

    Background: Tumor necrosis factor-α (TNF-α), may be involved in the pathogenesis of inflammatory bowel diseases (IBDs). The aim of this study was to evaluate the effect of TNF-α on the inflammatory activity of IBD. Methods: TNF-α mRNA expression in intestinal mucosal biopsy specimens...

  • Epithelial restitution and wound healing in inflammatory bowel disease. Sturm, Andreas; Dignass, Axel U.; Lakatos, Peter L. // World Journal of Gastroenterology;1/21/2008, Vol. 14 Issue 3, p348 

    Inflammatory bowel disease is characterized by a chronic inflammation of the intestinal mucosa. The mucosal epithelium of the alimentary tract constitutes a key element of the mucosal barrier to a broad spectrum of deleterious substances present within the intestinal lumen including bacterial...

  • IMMUNOPATHOGENESIS OF IBD: INSUFFICIENT SUPPRESSOR FUNCTION IN THE GUT? Huibregtse, I. L.; Van Lent, A. U.; Van Deventer, S. J. H. // Gut;Apr2007, Vol. 56 Issue 4, p584 

    The article offers insights into evidence for abnormal regulation of T cell activation in Crohn's disease, as well as data concerning the existence and functional activity of regulatory T cells in the intestinal mucosa. Regulatory T cells have important functions in suppressing unwanted...

  • Milk Fat Globule -- EGF Factor 8 Is a Critical Protein for Healing of Dextran Sodium Sulfate -- Induced Acute Colitis in Mice. Chogle, Ashish; Heng-Fu Bu; Xiao Wang; Brown, Jeffrey B.; Chou, Pauline M.; Xiao-Di Tan // Molecular Medicine;May/Jun2011, Vol. 17 Issue 5/6, p502 

    Milk fat globule-EGF factor 8 (MFG-E8) has been shown to play an important role in maintaining the integrity of the intestinal mucosa and to accelerate healing of the mucosa in septic mice. Herein, we (a) analyzed the expression of MFG-E8 in the gut of wild-type (WT) C57BL/6 (MFG-E8+/+) mice...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics